FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy.
Saved in:
| Title: | FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy. |
|---|---|
| Authors: | Gracilla DE; Tow Center for Developmental Oncology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Menon S; Tow Center for Developmental Oncology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Breese MR; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California., Lin YP; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California., Dela Cruz FS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Feinberg TY; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., de Stanchina E; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Galic AF; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Allegakoen H; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California., Perati SR; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California., Everin N; Tow Center for Developmental Oncology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Vizconde T; Tow Center for Developmental Oncology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Wen NJ; Tow Center for Developmental Oncology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Heslin A; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California., Somwar R; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Ladanyi M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Horlbeck M; Division of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts., Weissman JS; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California., Sweet-Cordero EA; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California., Bivona TG; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, California.; Chan Zuckerberg Biohub, San Francisco, California., Tulpule A; Tow Center for Developmental Oncology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York. |
| Source: | Cancer research [Cancer Res] 2026 Jun 01; Vol. 86 (11), pp. 2660-2677. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41811428 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gracilla+DE%22">Gracilla DE</searchLink>; Tow Center for Developmental Oncology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Menon+S%22">Menon S</searchLink>; Tow Center for Developmental Oncology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Breese+MR%22">Breese MR</searchLink>; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Lin+YP%22">Lin YP</searchLink>; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Dela+Cruz+FS%22">Dela Cruz FS</searchLink>; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Feinberg+TY%22">Feinberg TY</searchLink>; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22de+Stanchina+E%22">de Stanchina E</searchLink>; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Galic+AF%22">Galic AF</searchLink>; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Allegakoen+H%22">Allegakoen H</searchLink>; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Perati+SR%22">Perati SR</searchLink>; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Everin+N%22">Everin N</searchLink>; Tow Center for Developmental Oncology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Vizconde+T%22">Vizconde T</searchLink>; Tow Center for Developmental Oncology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Wen+NJ%22">Wen NJ</searchLink>; Tow Center for Developmental Oncology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Heslin+A%22">Heslin A</searchLink>; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Somwar+R%22">Somwar R</searchLink>; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Ladanyi+M%22">Ladanyi M</searchLink>; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Horlbeck+M%22">Horlbeck M</searchLink>; Division of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Weissman+JS%22">Weissman JS</searchLink>; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Sweet-Cordero+EA%22">Sweet-Cordero EA</searchLink>; Division of Pediatric Oncology, University of California, San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Bivona+TG%22">Bivona TG</searchLink>; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, California.; Chan Zuckerberg Biohub, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Tulpule+A%22">Tulpule A</searchLink>; Tow Center for Developmental Oncology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222984705R%22">Cancer research</searchLink> [Cancer Res] 2026 Jun 01; Vol. 86 (11), pp. 2660-2677. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2984705R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-7445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200085472%22">00085472 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41811428 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/0008-5472.CAN-25-2166 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2660 Titles: – TitleFull: FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gracilla DE – PersonEntity: Name: NameFull: Menon S – PersonEntity: Name: NameFull: Breese MR – PersonEntity: Name: NameFull: Lin YP – PersonEntity: Name: NameFull: Dela Cruz FS – PersonEntity: Name: NameFull: Feinberg TY – PersonEntity: Name: NameFull: de Stanchina E – PersonEntity: Name: NameFull: Galic AF – PersonEntity: Name: NameFull: Allegakoen H – PersonEntity: Name: NameFull: Perati SR – PersonEntity: Name: NameFull: Everin N – PersonEntity: Name: NameFull: Vizconde T – PersonEntity: Name: NameFull: Wen NJ – PersonEntity: Name: NameFull: Heslin A – PersonEntity: Name: NameFull: Somwar R – PersonEntity: Name: NameFull: Ladanyi M – PersonEntity: Name: NameFull: Horlbeck M – PersonEntity: Name: NameFull: Weissman JS – PersonEntity: Name: NameFull: Sweet-Cordero EA – PersonEntity: Name: NameFull: Bivona TG – PersonEntity: Name: NameFull: Tulpule A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1538-7445 Numbering: – Type: volume Value: 86 – Type: issue Value: 11 Titles: – TitleFull: Cancer research Type: main |
| ResultId | 1 |